ResearchMoz

GBI Research Market Research Reports

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

List of reports from GBI Research

Displaying 1 to 30 (of 601 records)
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
Feb 2015  
GBI Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4...
$6995
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation
Feb 2015  
Large and Innovative Pipeline The active pain pipeline is populated by 796 products across all stages of development, which exhibit a highly diverse range of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree...
$6995
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
Jan 2015  
Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast...
$6995
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches
Jan 2015  
GBI Research, a leading business intelligence provider, has released its latest research report: “Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches”. The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and...
$4995
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
Jan 2015  
GBI Research, the leading business intelligence provider, has released its latest research: “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the UK, France,...
$4995
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Europe (Germany, France, Italy, UK and Spain)
Dec 2014  
GBI Research’s report, ""Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 Europe (Germany, France, Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data...
$1750
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth
Nov 2014  
GBI Research, the leading business intelligence provider, has released its latest research, “Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 Increasing Uptake of Novel Drug Classes to Drive Market Growth”, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia. The report estimates the market size for...
$4995
Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation
Nov 2014  
Large Degree of Innovation in Parkinson’s Disease Pipeline The Parkinson’s disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors,...
$6995
Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
Nov 2014  
GBI Research’s report, “Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and...
$1750
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
Nov 2014  
GBI Research’s report, “Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and...
$1750
Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
Oct 2014  
Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly...
$6995
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies
Oct 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies ’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for...
$4995
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
Oct 2014  
GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts...
$4995
Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)
Oct 2014  
GBI Research’s report, “Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 US and Europe (US, Germany, France, Italy, UK, Spain)” provides quantitative analysis of the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis...
$1750
Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)
Oct 2014  
GBI Research’s report, “Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 US and Europe (US, Germany, France, Italy, UK, Spain)” provides quantitative analysis of the four cardiac rhythm management devices market segments: : cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The...
$1750
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
Oct 2014  
GBI Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany,...
$4995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)
Oct 2014  
The report covers the Europe (Germany, France, Italy, UK and Spain) aesthetic lasers and energy devices market revenue and volume for the following segments: Minimally Invasive Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) Devices and Laser Resurfacing (LR) Devices. The report also provides company shares by revenue for the above mentioned countries for the year...
$1750
Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)
Oct 2014  
GBI Research’s report, “Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes...
$1750
Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
Oct 2014  
GBI Research’s report, “Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: radiology PACS and cardiology PACS. It provides comprehensive...
$3500
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
Sep 2014  
GBI Research, a leading business intelligence provider, has released its latest research report “Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth.” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and,...
$4995
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
Sep 2014  
GBI Research, has released its latest pharma report - “Acute Myeloid Leukemia Therapeutics Market to 2020: Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts’. Treatment and prognosis in AML is strongly influenced by a patient’s age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher...
$4995
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
Sep 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting ’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for the...
$4995
Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)
Sep 2014  
GBI Research’s report, “Market Snapshot: Mammography Systems 2006 to 2020 Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following...
$1750
Market Digest: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)
Sep 2014  
GBI Research’s report, “Market Digest: Mammography Systems 2006 to 2020 Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following...
$1750
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
Aug 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM’, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region,...
$3500
Market Digest: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)
Aug 2014  
GBI Research’s report, “Market Digest: Transcatheter Heart Valve 2007 to 2020 Europe (Germany, France, Italy, UK, Spain)” provides quantitative analysis of the transcatheter heart valves market in Europe. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries:...
$1750
Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe
Aug 2014  
GBI Research’s report: “Transcatheter Heart Valve 2007 to 2020 – Europe” provides quantitative analysis of the transcatheter heart valves market in Europe. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: Germany, France, Italy, UK, Spain. It uses data...
$1750
Ventilators Market to 2020 - Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
Aug 2014  
Ventilators Market to 2020” discusses the market, competitive landscape, and trends for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes pipeline...
$3500
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
Jul 2014  
GBI Research, a leading business intelligence provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across...
$3500
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation
Jul 2014  
Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough...
$6995
 
Displaying 1 to 30 (of 601 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData